Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Genomic Health, Inc. (NASDAQ: GHDX).

Full DD Report for GHDX

You must become a subscriber to view this report.


Recent News from (NASDAQ: GHDX)

Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference
REDWOOD CITY, Calif. , May 9, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas on Wednesday, May 16, 2018 at 3:00 p.m. Pacific Time . To access the live a...
Source: PR Newswire
Date: May, 09 2018 08:00
Genomic Health's (GHDX) CEO Kimberly Popovits on Q1 2018 Results - Earnings Call Transcript
Genomic Health, Inc. (GHDX) Q1 2018 Earnings Conference Call May 02, 2018, 16:30 ET Executives Emily Faucette - VP, Corporate Communications & IR Kimberly Popovits - Chairman, CEO & President Bradley Cole - CFO Steven Shak - Co-Founder, Chief Scientific Officer & C...
Source: SeekingAlpha
Date: May, 02 2018 22:12
Genomic Health beats by $0.10, beats on revenue
Genomic Health (NASDAQ: GHDX ): Q1 EPS of -$0.11 beats by $0.10 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 02 2018 16:25
Genomic Health Announces First Quarter 2018 Financial Results and Reports Recent Business Progress
REDWOOD CITY, Calif. , May 2, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended March 31, 2018 . "In the first quarter of 2018, we delivered 13 percent growth in revenue and delivered a n...
Source: PR Newswire
Date: May, 02 2018 16:05
Large Independent Study Using the Oncotype DX® Test Accepted for Presentation at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
REDWOOD CITY, Calif. , April 26, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) has been informed of the acceptance of the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, for presentation by the ECOG-ACRIN Cancer Research Group (EC...
Source: PR Newswire
Date: April, 26 2018 08:00
Genomic Health to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 2, 2018
REDWOOD CITY, Calif. , April 25, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2018 financial results.&#x...
Source: PR Newswire
Date: April, 25 2018 08:00
Consolidated Research: 2018 Summary Expectations for AeroVironment, PS Business Parks, Genomic Health, Digi International, Sensient Technologies, and PolyOne - Fundamental Analysis, Key Performance Indications
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AeroVironment, Inc. (NASDAQ:AVAV), PS Business Parks, Inc. (NYSE:PSB), G...
Source: GlobeNewswire
Date: April, 24 2018 07:35
Epic Sciences and Genomic Health announces favorable draft LCD on medicare coverage for use of Oncotype DX AR-V7 Nucleus Detect test
Epic Sciences (Epic) and Genomic Health (NASDAQ: GHDX ) announces that Palmetto GBA, a Medicare Administrative Contractor (MAC) has issued a draft local coverage determination (LCD) for the Oncotype DX AR-V7 Nucleus Detect test. More news on: Genomic Health, Inc., Healthcare stocks ...
Source: SeekingAlpha
Date: April, 02 2018 07:54
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
SAN DIEGO and REDWOOD CITY, Calif. , March 30, 2018 /PRNewswire/ --  Epic Sciences, Inc. (Epic) and Genomic Health, Inc. (Nasdaq: GHDX) announced today that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued a ...
Source: PR Newswire
Date: March, 30 2018 08:00
Landmark TAILORx Results Aid in Assessing the Effect of Chemotherapy in Women with Early-stage Breast Cancer and Oncotype DX Breast Recurrence Score® Results of 11 to 25
REDWOOD CITY, Calif. , March 15, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) was informed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, has achieved sufficient information to...
Source: PR Newswire
Date: March, 15 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1738.0138.2438.3837.76152,103
2018-02-2632.7832.1333.0330.92353,616
2018-02-2331.5632.7833.0831.56251,600
2018-02-2232.8931.4033.2631.04306,263
2018-02-2132.6733.4834.7232.67176,399

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2031,199137,92622.6201Cover
2018-08-1719,25254,96035.0291Short
2018-08-1616,83062,35926.9889Cover
2018-08-1512,01765,53318.3373Cover
2018-08-1423,347100,61123.2052Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GHDX.


About Genomic Health, Inc. (NASDAQ: GHDX)

Logo for Genomic Health, Inc. (NASDAQ: GHDX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,341,267,240 - 05/16/2018
  • Issue and Outstanding: 35,380,653 - 04/30/2018

 


Recent Filings from (NASDAQ: GHDX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 14 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: March, 08 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: February, 20 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 25 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: December, 14 2017

 

 


Daily Technical Chart for (NASDAQ: GHDX)

Daily Technical Chart for (NASDAQ: GHDX)


Stay tuned for daily updates and more on (NASDAQ: GHDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: GHDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GHDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of GHDX and does not buy, sell, or trade any shares of GHDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/